Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hayes M Dansky

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Lipid Research|July 15, 2006
Addition of dietary fat to cholesterol in the diets of LDL receptor knockout mice: effects on plasma insulin, lipoproteins, and atherosclerosisLan Wu, Reeba Vikramadithyan, Shuiqing Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2002
Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient miceEugene Trogan, Robin P Choudhury, Hayes M Dansky, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 14, 2003
In silico quantitative trait locus map for atherosclerosis susceptibility in apolipoprotein E-deficient miceJonathan D Smith, Daylon James, Hayes M Dansky, et al.
Circulation|July 6, 2006
Increased neointimal formation after surgical vein grafting in a murine model of type 2 diabetesSacha P Salzberg, Farzan Filsoufi, Anelechi Anyanwu, et al.
American Heart Journal|October 11, 2011
Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemiaHayes M Dansky, Daniel Bloomfield, Patrice Gibbons, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|March 7, 2006
Transcriptome profile of macrophages from atherosclerosis-sensitive and atherosclerosis-resistant miceJonathan D Smith, Dao-Quan Peng, Hayes M Dansky, et al.
Contemporary Clinical Trials|September 12, 2025
Design of RESOLVE Lung, a multinational Phase 2, randomized, placebo-controlled trial of the anti-GM-CSF monoclonal antibody namilumab in patients with chronic pulmonary sarcoidosisBernt van den Blink, Chantal M Petit, Hayes M Dansky, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 21, 2004
High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidationRobin P Choudhury, James X Rong, Eugene Trogan, et al.
Journal of Lipid Research|November 23, 2012
Measurement of LDL-C after treatment with the CETP inhibitor anacetrapibMichael Davidson, Sherry Xueyu Liu, Philip Barter, et al.
JACC. Cardiovascular Imaging|January 14, 2012
Correlation between arterial FDG uptake and biomarkers in peripheral artery diseaseKelly S Myers, James H F Rudd, Eric P Hailman, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Lipid Research|July 15, 2006
Addition of dietary fat to cholesterol in the diets of LDL receptor knockout mice: effects on plasma insulin, lipoproteins, and atherosclerosisLan Wu, Reeba Vikramadithyan, Shuiqing Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2002
Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient miceEugene Trogan, Robin P Choudhury, Hayes M Dansky, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 14, 2003
In silico quantitative trait locus map for atherosclerosis susceptibility in apolipoprotein E-deficient miceJonathan D Smith, Daylon James, Hayes M Dansky, et al.
Circulation|July 6, 2006
Increased neointimal formation after surgical vein grafting in a murine model of type 2 diabetesSacha P Salzberg, Farzan Filsoufi, Anelechi Anyanwu, et al.
American Heart Journal|October 11, 2011
Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemiaHayes M Dansky, Daniel Bloomfield, Patrice Gibbons, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|March 7, 2006
Transcriptome profile of macrophages from atherosclerosis-sensitive and atherosclerosis-resistant miceJonathan D Smith, Dao-Quan Peng, Hayes M Dansky, et al.
Contemporary Clinical Trials|September 12, 2025
Design of RESOLVE Lung, a multinational Phase 2, randomized, placebo-controlled trial of the anti-GM-CSF monoclonal antibody namilumab in patients with chronic pulmonary sarcoidosisBernt van den Blink, Chantal M Petit, Hayes M Dansky, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 21, 2004
High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidationRobin P Choudhury, James X Rong, Eugene Trogan, et al.
Journal of Lipid Research|November 23, 2012
Measurement of LDL-C after treatment with the CETP inhibitor anacetrapibMichael Davidson, Sherry Xueyu Liu, Philip Barter, et al.
JACC. Cardiovascular Imaging|January 14, 2012
Correlation between arterial FDG uptake and biomarkers in peripheral artery diseaseKelly S Myers, James H F Rudd, Eric P Hailman, et al.
Pageof 3